Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 7/14/2008 First Published: 8/1/2001


1.		Phase III Randomized Study of Zoledronate, Calcium, and Cholecalciferol (Vitamin D) to Prevent Bone Loss in Women With Breast Cancer Receiving Adjuvant Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				40 and over				NCI				CALGB-79809 NCI-P01-0184, CALGB-79809, NCT00022087

Last Modified: 6/16/2008 First Published: 4/14/2006


2.		Phase III Randomized Study of Calcium Gluconate and Magnesium Sulfate in Preventing Oxaliplatin-Induced Neurotoxicity in Patients Receiving Adjuvant FOLFOX Combination Chemotherapy for Stage II, III, or Resected Stage IV Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Supportive care, Treatment				Closed				18 and over				NCI				NCCTG-N04C7 N04C7, NCT00316914

Last Modified: 6/2/2008 First Published: 7/14/2006


3.		Phase III Companion Study of Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Treated on Protocol CAN-NCIC-MA27

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Natural history/Epidemiology, Supportive care				Closed				45 and over				NCI				CAN-NCIC-MA27B NCIC-MA.27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, NCT00354302, MA27B


4.		Women's Health Initiative (WHI)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Health services research, Natural history/Epidemiology, Prevention				Completed				50 to 79				NCI, NHLBI				114 NCT00000611


5.		Chemotherapy with BCNU/CTX/PRED vs L-PAM/PRED with FXM/Sodium Fluoride/Calcium Gluconate/Vitamin D for Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Completed				no age specified				NCI				EST-4472 SEG-343

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute